Literature DB >> 25605720

The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.

Thorsten Maretzky1, Astrid Evers2, Sylvain Le Gall1, Rolake O Alabi3, Nancy Speck4, Karina Reiss4, Carl P Blobel5.   

Abstract

The membrane-anchored metalloproteinase a disintegrin and metalloprotease 10 (ADAM10) is required for shedding of membrane proteins such as EGF, betacellulin, the amyloid precursor protein, and CD23 from cells. ADAM10 is constitutively active and can be rapidly and post-translationally enhanced by several stimuli, yet little is known about the underlying mechanism. Here, we use ADAM10-deficient cells transfected with wild type or mutant ADAM10 to address the role of its cytoplasmic and transmembrane domain in regulating ADAM10-dependent protein ectodomain shedding. We report that the cytoplasmic domain of ADAM10 negatively regulates its constitutive activity through an ER retention motif but is dispensable for its stimulated activity. However, chimeras with the extracellular domain of ADAM10 and the transmembrane domain of ADAM17 with or without the cytoplasmic domain of ADAM17 show reduced stimulated shedding of the ADAM10 substrate betacellulin, whereas the ionomycin-stimulated shedding of the ADAM17 substrates CD62-L and TGFα is not affected. Moreover, we show that influx of extracellular calcium activates ADAM10 but is not essential for its activation by APMA and BzATP. Finally, the rapid stimulation of ADAM10 is not significantly affected by incubation with proprotein convertase inhibitors for up to 8 h, arguing against a major role of increased prodomain removal in the rapid stimulation of ADAM10. Thus, the cytoplasmic domain of ADAM10 negatively influences constitutive shedding through an ER retention motif, whereas the cytoplasmic domain and prodomain processing are not required for the rapid activation of ADAM10-dependent shedding events.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ADAM; Cell Surface Enzyme; Cytoplasmic Domain; Metalloprotease; Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9); Protein Ectodomain Shedding; Shedding

Mesh:

Substances:

Year:  2015        PMID: 25605720      PMCID: PMC4367251          DOI: 10.1074/jbc.M114.603753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases.

Authors:  A Anders; S Gilbert; W Garten; R Postina; F Fahrenholz
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

2.  ADAM 10: an active metalloprotease expressed during avian epithelial morphogenesis.

Authors:  Ronelle J Hall; Carol A Erickson
Journal:  Dev Biol       Date:  2003-04-01       Impact factor: 3.582

3.  Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE.

Authors:  Colin Adrain; Markus Zettl; Yonka Christova; Neil Taylor; Matthew Freeman
Journal:  Science       Date:  2012-01-13       Impact factor: 47.728

4.  Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE).

Authors:  J Schlöndorff; J D Becherer; C P Blobel
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

5.  Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1.

Authors:  Yufang Zheng; Johannes Schlondorff; Carl P Blobel
Journal:  J Biol Chem       Date:  2002-08-30       Impact factor: 5.157

6.  A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.

Authors:  Rolf Postina; Anja Schroeder; Ilse Dewachter; Juergen Bohl; Ulrich Schmitt; Elzbieta Kojro; Claudia Prinzen; Kristina Endres; Christoph Hiemke; Manfred Blessing; Pascaline Flamez; Antoine Dequenne; Emile Godaux; Fred van Leuven; Falk Fahrenholz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  The effect of ionomycin on calcium fluxes in sarcoplasmic reticulum vesicles and liposomes.

Authors:  T J Beeler; I Jona; A Martonosi
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

8.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

9.  TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation.

Authors:  John R Doedens; Rajeev M Mahimkar; Roy A Black
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

10.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.

Authors:  Umut Sahin; Gisela Weskamp; Kristine Kelly; Hong-Ming Zhou; Shigeki Higashiyama; Jacques Peschon; Dieter Hartmann; Paul Saftig; Carl P Blobel
Journal:  J Cell Biol       Date:  2004-03-01       Impact factor: 10.539

View more
  17 in total

1.  Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44.

Authors:  Liseth M Parra; Monika Hartmann; Salome Schubach; Yong Li; Peter Herrlich; Andreas Herrlich
Journal:  Mol Cell Biol       Date:  2015-07-27       Impact factor: 4.272

Review 2.  The ADAMs family of proteases as targets for the treatment of cancer.

Authors:  Maeve Mullooly; Patricia M McGowan; John Crown; Michael J Duffy
Journal:  Cancer Biol Ther       Date:  2016-04-26       Impact factor: 4.742

3.  Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.

Authors:  Chuan Xia; Madhuvanthi Vijayan; Curtis J Pritzl; Serge Y Fuchs; Adrian B McDermott; Bumsuk Hahm
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

4.  Cleavage of Signal Regulatory Protein α (SIRPα) Enhances Inflammatory Signaling.

Authors:  James D Londino; Dexter Gulick; Jeffrey S Isenberg; Rama K Mallampalli
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

5.  ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.

Authors:  Marlies Sachs; Sebastian Wetzel; Julia Reichelt; Wiebke Sachs; Lisa Schebsdat; Stephanie Zielinski; Lisa Seipold; Lukas Heintz; Stephan A Müller; Oliver Kretz; Maja Lindenmeyer; Thorsten Wiech; Tobias B Huber; Renate Lüllmann-Rauch; Stefan F Lichtenthaler; Paul Saftig; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2021-03-30       Impact factor: 14.978

6.  Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility.

Authors:  Liseth M Parra; Monika Hartmann; Salome Schubach; Junzhi Ma; Peter Herrlich; Andreas Herrlich
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 7.  Scissor sisters: regulation of ADAM10 by the TspanC8 tetraspanins.

Authors:  Alexandra L Matthews; Justyna Szyroka; Richard Collier; Peter J Noy; Michael G Tomlinson
Journal:  Biochem Soc Trans       Date:  2017-06-15       Impact factor: 5.407

Review 8.  Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.

Authors:  Kristina Endres; Thomas Deller
Journal:  Front Mol Neurosci       Date:  2017-03-17       Impact factor: 5.639

9.  MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.

Authors:  Gang Wu; Kunming Zheng; Shuguan Xia; Yawei Wang; Xiangyu Meng; Xiaoming Qin; Ying Cheng
Journal:  J Exp Clin Cancer Res       Date:  2016-06-04

Review 10.  Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.

Authors:  Alexandra L Matthews; Peter J Noy; Jasmeet S Reyat; Michael G Tomlinson
Journal:  Platelets       Date:  2016-06-02       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.